metabolically related fatty liver disease
Conditions
Interventions
Group of type 2 diabetes mellitus with metabolism-related fatty liver disease:None
Sponsors
Zhongda Hospital Affiliated to Southeast University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-70 years; 2. According to the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes, the patient was diagnosed with T2DM; 3. Liver hardness and fat attenuation parameters were measured based on iLivTouch; 4. The subject (or his legal guardian) understands the requirements of the clinical trial and has signed an informed consent prior to performing any special tests related to the trial; 5. Subjects agree to and are able to complete all follow-up evaluations required for this study.
Exclusion criteria
Exclusion criteria: 1. Confirmed cases of viral hepatitis and hepatic schistosomiasis; 2. A diagnosis of malignancy or high risk of cancer/recurrence, or a life expectancy of less than 60 months; 3. Currently participating in clinical trials of other drugs or medical devices, and have not yet completed the primary study endpoint of the study; 4. Pregnant or lactating patients, or patients who plan to become pregnant within 1 year (women of childbearing age must undergo a pregnancy test within 7 days prior to baseline surgery); 5. History of alcohol/drug/substance abuse; 6. Conditions that affect subject safety or otherwise interfere with the evaluation of test results as determined by the investigator; 7. Patients with incomplete data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence;risk factors; | — |
Countries
China
Contacts
Public ContactLi Ling
Outcome results
None listed